Interleukin (IL)-25 suppresses IL-22 induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

Hong Ki Min(Soonchunhyang University Hospital Seoul), Kyoung‐Woon Kim(Catholic University of Korea)

Research Square

December 20, 2019

10.21203/rs.2.19355/v1

Cited by 0

Related Papers

Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor κB-dependent pathway in patients with rheumatoid arthritis

|Arthritis Research & Therapy|2004|112

Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease

|Stem Cell Research & Therapy|2015|48

The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation <i>in vitro</i> and <i>in vivo</i> in kidney transplant recipients

|Immunology|2014|46

Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

|Arthritis Research & Therapy|2020|36

Intravenous Immunoglobulin Controls Th17 Cell-Mediated Osteoclastogenesis

|Immune Network|2019|5